SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Graphite Bio, Inc. (Nasdaq: GRPH), a clinical-stage, next-generation gene editing company harnessing the power of high-efficiency precision gene repair to ...
THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES First Graphite Corp. (TSX VENTURE:FGR.V - News) (the "Company" or "First Graphite") is pleased to announce that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback